Volume 10,Issue 4
Survey on Medication Compliance among Community Patients with Chronic Diseases and Evaluation of the Effectiveness of Pharmaceutical Service Intervention
Purpose: To investigate the medication compliance of patients with chronic diseases in the community, and use the method of pharmaceutical service intervention as the research method to explore the effect of pharmaceutical service intervention for patients with chronic diseases in the community. Methods: 89 chronic disease patients treated in this community from January 2024 to December 2024 were selected, and all patients received pharmaceutical service intervention. Statistics were made on the types of drugs consulted by patients, and comparative analysis was conducted on patients' medication compliance and intervention satisfaction before and after intervention. Results: The patients with the largest number of consultations were over 60 years old, with 49 consultations, accounting for 55.06%. Patients under 40 years old had fewer consultations, with 17 cases, accounting for 19.1%. The largest number of patients consulted for cardiovascular and cerebrovascular system drugs, with 29 cases, accounting for 32.58%, followed by digestive system medication, with 18 cases, accounting for 20.22%. The medication compliance of patients after the intervention was significantly better than before the intervention (P<0.05). After the intervention, patients' satisfaction with outpatient services has significantly improved, and the difference is statistically significant (P<0.05). Conclusion: Implementing pharmaceutical service intervention for community patients with chronic diseases can not only improve patients' medication compliance, but also significantly improve patient satisfaction with the intervention, which is worthy of clinical promotion.
[1] Xu T, 2024, Evaluation of Clinical Pharmacy Services in Improving Treatment Compliance and Effectiveness of Outpatient Hypertension Patients. Chinese Science and Technology Journal Database (Citation Edition) Medicine and Health, (2): 0081-0084.
[2] Zhang SD, Sun CF, 2024, Analysis of the Impact of Pharmaceutical Service Intervention on Medication Compliance and Efficacy in Patients with Hypertension. Chinese Science and Technology Journal Database (Abstract Edition) Medicine and Health, (12): 245-248.
[3] Gu Y, Li X, Yang YX, et al., 2024, Evaluation of the Management Effect of the PDCA Home Pharmacy Service Model on Patients with Hypertension of the Bai Ethnic Group in Dali. Chinese Medical Science, 14(6): 105-108.
[4] Zhang B, 2024, Analysis of the Clinical Effect of Community Pharmaceutical Services in the Health Management of Patients with Type 2 Diabetes. Chinese Community Physicians, 40(19): 10-12.
[5] Sun GP, 2024, Observation on the Application of Health Guidance in the Intervention of Chronic Diseases in the Elderly Hypertension Community. China Science and Technology Journal Database Medicine, (7): 0158-0161.
[6] Hu YF, 2024, Intervention Study on the Effect of Family Doctor Contract Service on Disease Cognition and Blood Pressure Control in Community Patients with Hypertension. China Science and Technology Journal Database Medicine, (12): 073-077.
[7] Fu LF, 2024, Impact of Pharmaceutical Services on Compliance and Blood Sugar Control in Patients with Type 2 Diabetes Using Liraglutide Injection. Chinese Science and Technology Journal Database (Citation Edition) Medicine and Health, (11): 083-086.
[8] Wang CL, 2024, The Impact of Pharmaceutical Service Intervention on Community-Based Multidrug-Controlled Type 2 Diabetes Patients. Chinese Science and Technology Journal Database (Abstract Edition) Medicine and Health, (4): 0113-0116.